ResMed Inc.

NYQ: RMD
Live Quote

📈 ZcoreAI Score

Our AI model analyzes ResMed Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get RMD Z-Score →

About ResMed Inc.

Healthcare Medical Instruments & Supplies
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

📊 Fundamental Analysis

ResMed Inc. demonstrates exceptional profitability, with a profit margin of 27.5%.

The company recently reported 11.0% revenue growth, which is above average for the Healthcare sector.

Return on Equity (ROE) is 25.7%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.

At a current price of $228.87, RMD currently sits at the 29th percentile of its 52-week range (Range: $202.00 - $293.81).

💰 Valuation Insight

RMD is valued broadly in line with the sector at a PE of 22.62. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

Profit Margin Excellent
Debt/Equity Excellent
⚠️ Revenue Growth Moderate
⚠️ Return on Equity Moderate
⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap
$33.41B
Trailing P/E
22.62
Forward P/E
18.80
Beta (5Y)
0.93
52W High
$293.81
52W Low
$202.00
Avg Volume
1.11M
Day High
Day Low
Get RMD Z-Score on Dashboard 🚀